Figure 2.
Figure 2. Overall and progression free survival of concurrent BCL2 and MYC protein positive cases according to DLBCL subtypes as assigned by the Lymph2Cx.

Overall and progression free survival of concurrent BCL2 and MYC protein positive cases according to DLBCL subtypes as assigned by the Lymph2Cx.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal